Kura Oncology, Inc. (KURA) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Kura Oncology, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.000 -- 00:00:03.980 Stand by, your program is about to begin. 00:00:05.780 -- 00:00:11.280 Hello and welcome everyone joining today's second quarter 2025 Cura Oncology 00:00:11.280 -- 00:00:16.540 Inc. Financial Results Conference call. At this time all participants are in a listen-only 00:00:16.540 -- 00:00:21.140 mode. Later you will have an opportunity to ask questions during the question and answer 00:00:21.140 -- 00:00:26.340 session. You may register to ask a question at any time by pressing star and 1 on your 00:00:26.340 -- 00:00:29.260 telephone keypad. Please note this call is being recorded. 00:00:29.260 -- 00:00:31.880 I am standing by should you need any assistance. 00:00:31.880 -- 00:00:36.800 It is now my pleasure to turn the meeting over to Greg Mann, SVP of Investor Relations 00:00:36.800 -- 00:00:40.540 and Corporate Affairs. Please go ahead. 00:00:40.640 -- 00:00:45.620 Thank you, Brittany. Good afternoon and welcome to Cura Oncology's second quarter 2025 00:00:45.620 -- 00:00:48.800 conference call. Joining the call today are Dr. 00:00:48.800 -- 00:00:52.020 Troy Wilson, President and Chief Executive Officer, Dr. 00:00:52.020 -- 00:00:57.200 Molly Leone, Chief Medical Officer, Brian Powell, Chief Commercial Officer, and Tom 00:00:57.200 -- 00:01:00.640 Doyle, Senior Vice President of Finance and Accounting. 00:01:00.640 -- 00:01:04.740 Before I turn the call over to Dr. Wilson, we remind you that today's call will include 00:01:04.740 -- 00:01:08.120 forward-looking statements based on current expectations. 00:01:08.120 -- 00:01:12.620 Such statements represent management's judgment as of today and may involve risks and 00:01:12.620 -- 00:01:17.480 uncertainties that cause actual results to differ materially from expected results. ...